Oxford Glycosciences ucb-group.com


Public lists: Pharma Startups (6570)

was a technology developer in the fields of glycobiology and proteomics. Utilizing its technology, the company developed a lead pharmaceutical product Zavesca, that was approved by the European Commission, and established proteomics collaborations with several multi-national pharmaceutical companies.

was a technology developer in the fields of glycobiology and proteomics. Utilizing its technology, the company developed a lead pharmaceutical product Zavesca, that was approved by the European Commission, and established proteomics collaborations wi...Show all

Company (Acquired)

Phone:

Fax:

1950 Lake Park Drive

Smyrna, 30080
Georgia, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Oxford Glycosciences $50M Apr 11, 2003
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Oxford Glycosciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
SR OneCorporate VentureCambridge, Massachusetts, United StatesOther Investors
Edelson Technology PartnersVenture CapitalNew Jersey, United StatesOther Investors
Thomas McNerney & PartnersVenture CapitalStamford, Connecticut, United StatesOther Investors
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Ephrin-b receptor protein involved in carcinoma Apr 09, 2003 Feb 02, 2010 Patent